Join to View Full Profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-520-5000
Fax+1 315-335-7623
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pradeep Singh, MD is a pulmonologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Iowa.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1999- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1989 - 1992
Northwestern University The Feinberg School of MedicineClass of 1989
Certifications & Licensure
WA State Medical License 2006 - 2026
IA State Medical License 1995 - 2007
American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 9 citationsElexacaftor/Tezacaftor/Ivacaftor Markedly Reducesin Cystic Fibrosis.Sarah J Morgan, David P Nichols, Windy Ni, Gina Hong, Stephen J Salipante
American Journal of Respiratory and Critical Care Medicine. 2024-11-01 - 9 citationsElexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment.Sarah J Morgan, Ellis Coulter, Hannah L Betts, George M Solomon, John P Clancy
The Journal of Clinical Investigation. 2024-09-05 - 2 citationsCell-Free DNA DetectsLung Infection in Modulator-treated People with Cystic Fibrosis.Dustin R Long, Elizabeth A Holmes, Christopher H Goss, Pradeep K Singh, Adam Waalkes
American Journal of Respiratory and Critical Care Medicine. 2023-11-01
Press Mentions
Lung Infections in Cystic Fibrosis: New Research Reveals Unexpected PersistenceAugust 6th, 2025- Going in for a Close Look at Lung InfectionsAugust 5th, 2025
